Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Edwards

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|April 5, 2016
A Prospective Virtual Screening Study: Enriching Hit Rates and Designing Focus Libraries To Find Inhibitors of PI3Kδ and PI3KγKelly L Damm-Ganamet, Scott D Bembenek, Jennifer W Venable, et al.
ACS Medicinal Chemistry Letters|March 20, 2024
Discovery of Alternative Binding Poses through Fragment-Based Identification of DHODH InhibitorsLindsey G DeRatt, E Christine Pietsch, Justin S Cisar, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophoreLin Zhi, Josef D Ringgenberg, James P Edwards, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2006
Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligandsAlice Lee-Dutra, Kristen L Arienti, Daniel J Buzard, et al.
Journal of Chemical Information and Modeling|March 1, 2019
Accelerating Lead Identification by High Throughput Virtual Screening: Prospective Case Studies from the Pharmaceutical IndustryKelly L Damm-Ganamet, Nidhi Arora, Stephane Becart, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2006
The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitorsCheryl A Grice, Kevin Tays, Haripada Khatuya, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 21, 2007
Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileutonNavin L Rao, Paul J Dunford, Xiaohua Xue, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2004
A potent and selective histamine H4 receptor antagonist with anti-inflammatory propertiesRobin L Thurmond, Pragnya J Desai, Paul J Dunford, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2010
Diazinones as P2 replacements for pyrazole-based cathepsin S inhibitorsMichael K Ameriks, Scott D Bembenek, Matthew T Burdett, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2020
Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approachChristoph Steeneck, Christian Gege, Olaf Kinzel, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|April 5, 2016
A Prospective Virtual Screening Study: Enriching Hit Rates and Designing Focus Libraries To Find Inhibitors of PI3Kδ and PI3KγKelly L Damm-Ganamet, Scott D Bembenek, Jennifer W Venable, et al.
ACS Medicinal Chemistry Letters|March 20, 2024
Discovery of Alternative Binding Poses through Fragment-Based Identification of DHODH InhibitorsLindsey G DeRatt, E Christine Pietsch, Justin S Cisar, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophoreLin Zhi, Josef D Ringgenberg, James P Edwards, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2006
Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligandsAlice Lee-Dutra, Kristen L Arienti, Daniel J Buzard, et al.
Journal of Chemical Information and Modeling|March 1, 2019
Accelerating Lead Identification by High Throughput Virtual Screening: Prospective Case Studies from the Pharmaceutical IndustryKelly L Damm-Ganamet, Nidhi Arora, Stephane Becart, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2006
The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitorsCheryl A Grice, Kevin Tays, Haripada Khatuya, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 21, 2007
Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileutonNavin L Rao, Paul J Dunford, Xiaohua Xue, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2004
A potent and selective histamine H4 receptor antagonist with anti-inflammatory propertiesRobin L Thurmond, Pragnya J Desai, Paul J Dunford, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2010
Diazinones as P2 replacements for pyrazole-based cathepsin S inhibitorsMichael K Ameriks, Scott D Bembenek, Matthew T Burdett, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2020
Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approachChristoph Steeneck, Christian Gege, Olaf Kinzel, et al.
Pageof 8